Jazz Pharmaceuticals stock price target raised to $167 from $163 at Morgan Stanley
PositiveFinancial Markets

Morgan Stanley has raised its price target for Jazz Pharmaceuticals from $163 to $167, reflecting confidence in the company's growth potential. This adjustment is significant as it indicates analysts' positive outlook on Jazz's performance, which could attract more investors and boost the stock's value. Such changes in price targets often influence market perceptions and can lead to increased trading activity.
— Curated by the World Pulse Now AI Editorial System